Background Analysis: US FDA Advisory Committee to Review Drugs and Bulk Substances Allowed for Pharmacy Compounding – FEB 23-24, 2015 (PCAC)
The US FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) Meeting for Monday and Tuesday, February 23–24, 2015, to discuss revisions to the list of drugs that may or may not be compounded and creation of the list of bulk substances that may be used to compound drug products under the Food, Drug, & Cosmetic Act (FD&C) Act.